Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1055)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2694)
  2. Department of Medicine (2694)
  3. Hematologic Malignancies, Division of (2694)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (654)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (443)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (41)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2694)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of patients with common peripheral T-cell lymphoma subtypes from a phase 2 study of romidepsin in relapsed or refractory peripheral T-cell lymphoma
    Meeting Abstract

    Coiffier, B.; Pro, B.; Prince, H. M.; Foss, F. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Borchmann, P.; Morschhauser, F.; Wilhelm, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Older age and co-morbidities do not predict incidence of dose limiting toxicities in lymphoma phase I trials at MSKCC
    Meeting Abstract

    Ammakkanavar, N. R.; Leon, C. A.; Hamlin, P.
    Blood (2011)

    Fulltext@MSK | Save
  • Testis-isolated mantle cell lymphoma: A unique case
    Journal Article

    Epstein, A. S.; Hedvat, C.; Habib, F.; Hamlin, P.
    Clinical Lymphoma, Myeloma and Leukemia (2011)

    Fulltext@MSK | Save
  • Electronic chemotherapy order entry: A major cancer center's implementation
    Journal Article

    Sklarin, N. T.; Granovsky, S.; O'Reilly, E. M.; Zelenetz, A. D.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save
  • Entecavir is effective in preventing Hepatitis B reactivation in cancer patients receiving chemotherapy
    Meeting Abstract

    Mendelsohn, R. B.; Ng, G.; Patel, D.; Taur, Y.; Kamboj, M.; Zelenetz, A. D.; Sepkowitz, K.; Ludwig, E.
    Hepatology (2011)

    Fulltext@MSK | Save
  • Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
    Journal Article

    Schatz, J. H.; Oricchio, E.; Wolfe, A. L.; Jiang, M.; Linkov, I.; Maragulia, J.; Shi, W.; Zhang, Z.; Rajasekhar, V. K.; Pagano, N. C.; more...
    Journal of Experimental Medicine (2011)

    Fulltext@MSK | Save
  • NCCN biosimilars white paper: Regulatory, scientific, and patient safety perspectives
    Journal Article

    Zelenetz, A. D.; Ahmed, I.; Braud, E. L.; Cross, J. D.; Davenport-Ennis, N.; Dickinson, B. D.; Goldberg, S. E.; Gottlieb, S.; Johnson, P. E.; Lyman, G. H.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
    Journal Article

    Kempf, W.; Pfaltz, K.; Vermeer, M. H.; Cozzio, A.; Ortiz-Romero, P. L.; Bagot, M.; Olsen, E.; Kim, Y. H.; Dummer, R.; Pimpinelli, N.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Chemotherapy only for localized Hodgkin lymphoma
    Journal Article

    Straus, D. J.
    Journal of Internal Medicine (2011)

    Fulltext@MSK | Save
  • Targeting cap-dependent translation to bypass pro-survival signaling by AKT and the Pim family kinases in non-Hodgkin lymphoma
    Meeting Abstract

    Schatz, J. H.; Teruya-Feldstein, J.; Jiang, M.; Zelenetz, A.; Wendel, H.
    Annals of Oncology (2011)

    Fulltext@MSK | Save